Fingertip patch monitors Parkinson's medication levels through sweat

A groundbreaking wearable patch, designed to be worn on the fingertip, is offering new hope for Parkinson's disease patients by continuously monitoring their medication levels. Developed by a team of neuroscientists and engineers from the University of California, San Diego, the experimental device tracks the levels of levodopa, the primary drug used to manage the motor control loss associated with Parkinson's.

“

Reducing it leaves patients unable to move, while an excess triggers severe and uncontrollable spasmodic movements.

The challenge with levodopa lies in its narrow therapeutic window. Too little medication leaves patients immobile, while too much can trigger severe, uncontrollable involuntary movements. As Parkinson's progresses, this window often shrinks, making precise dosage adjustments critical. Traditionally, doctors have relied on patients' subjective daily logs to fine-tune treatment, a method prone to inaccuracies.

This new portable patch utilizes the body's own sweat to measure levodopa concentrations in real-time. The fingertip, chosen for its high density of sweat glands, hosts a specially designed absorbent gel. This gel acts like a sponge, drawing sweat from pores and initiating a chemical reaction when levodopa comes into contact with embedded enzymes. This reaction generates a measurable electrical voltage, which directly correlates with the patient's medication level.

“

This reaction chemical is what powers the patch.

Clinical trials involving both healthy volunteers and Parkinson's patients have shown the patch to be as accurate as standard laboratory blood tests, but with the significant advantage of providing immediate, continuous data. Intriguingly, the trials revealed that Parkinson's patients metabolize levodopa significantly faster than healthy individuals, potentially explaining the sudden worsening of symptoms that many experience. Researchers believe this technology lays the foundation for a closed-loop system, where the monitoring patch could communicate with an automated drug delivery device.

“

This result explains why the symptoms of the disease can worsen so suddenly.